Healthy Volunteers Clinical Trial
Official title:
Comparison of the Effects of 6-Week Vibration and Non-Vibration Foam Rolling on Neuromuscular Control and Performance in Male Soccer Players
Verified date | October 2023 |
Source | Celal Bayar University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players.
Status | Completed |
Enrollment | 36 |
Est. completion date | October 2, 2023 |
Est. primary completion date | September 25, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 22 Years |
Eligibility | Inclusion Criteria: - Volunteering to participate in the study. - To regularly participate in team training within the club. - To have been playing football for at least 1 year in the category. Exclusion Criteria: - Having any sports injury involving the lower extremity and/or spine in the last 3 months. - Having a problem (vertigo, neuropathy, etc.) that may negatively affect balance and coordination. - Having a musculoskeletal deformity (short limb, etc.) concerning the lower and upper extremities. - Implementing a training program outside of routine team training |
Country | Name | City | State |
---|---|---|---|
Turkey | Izmir Katip Celebi University | Izmir |
Lead Sponsor | Collaborator |
---|---|
Celal Bayar University | Izmir Katip Celebi University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Knee Flexor and Extensor Muscle Strength | Participants' knee flexor and extensor muscle strength will be evaluated with the Lafayette manual muscle test device (Lafayette Instrument Company, Lafayette IN, USA).This device is a valid and reliable method that is frequently used in the evaluation of muscle strength.
During the evaluation, participants will be asked to perform a maximum isometric contraction for 3 seconds with the muscle in which the muscle strength is evaluated against the resistance to be applied with the manual muscle test device. Measurements will be repeated 3 times with one minute intervals for the right and left sides and the average of the measured values will be used for analysis. |
A week | |
Primary | Knee Flexor and Extensor Muscle Strength Ratio (H/Q Ratio) | Participants' Hamstring/Quadriceps muscle strength ratio will be evaluated with the Lafayette manual muscle test device (Lafayette Instrument Company, Lafayette IN, USA). This device is a valid and reliable method that is frequently used in the evaluation of muscle strength. The Hamstring/Quadriceps muscle strength ratio will be determined by the ratio of the knee flexor and extensor muscle strengths obtained during the measurements. | A week | |
Primary | Flexibility | The flexibility will be evaluated whit the sit-and-reach test. The testing box will be fixed to the wall, and participants will be requested to sit with their knees extended and the soles of their feet against the testing box. Then participants will be requested to slowly reach forward as far as possible along the top of the box and hold the position for 2 seconds without bending their knees. The average of the two trials will be used for analysis. | A week | |
Secondary | Dynamic Balance | Dynamic balance will be evaluated with the Y balance test. The test is a valid and reliable method that was developed as a version of the Star Excursion Balance Test (SEBT) to improve repeatability and standardize the performance. During the preparation of the test, three tape measures; between the anterior and the posterolateral/posteromedial directions, will be fixed to the ground with 135° angles. The measurement will be done for the dominant side three times after the trial and the average of the endpoints where the athletes could reach will be used for analysis. The greater the distance the participants can reach during the test, the better participant's dynamic balance performance. | A week | |
Secondary | Agility | Agility will be evaluated with the agility T-test. The test is a valid and reliable method used in the assessment of agility performance. For this test, an agility circuit will be created with 4 cones named 1, 2, 3, and 4. Cones will also set up at a distance of 10 yards between 1 and 2, and 5 yards between 2, and 3, 2, and 4. At the "go" command, the participant will sprint forward from cone 1 to cone 2, sidestepped to cone 3, sidestepped to cone 4, sidestepped to cone 2, then backpedal as fast as possible to cone 1. A stopwatch will be used during the test. The test will be performed 2 times with at least 2-minute rest periods between trials. The average of the 2 trials will be used for data analysis. | A week | |
Secondary | Sprint | Sprint performance will be evaluated with the 20-m sprint test. The test is a valid and reliable method used in studies to evaluate sprint performance. During the test, at the "go" command, the participant will be asked to complete the 20-meter distance as quickly as possible, and a stopwatch will be used to determine the time to complete the test. All participants will performed the test 2 times with at least 2-minute rest periods between trials. The average of the 2 trials will be used for data analysis. | A week | |
Secondary | Reaction Time | Lower-extremity V-MRT will be evaluated with the Test You Brain Pro System. This system is a method that consists of 6 semaphores (sensors), 6 stabilizers, 1 charging cable, and 1 tablet and assesses and trains the reaction time of individuals in many different environments. Before the assessments, 6 semaphores (light and sound stimuli) will be positioned to form a 180° semicircle, with each semaphore placed in increments of 45° around the semicircle.Participants will perform the test three times with 30-second intervals after one trial with their right lower-extremity, left lower-extremity, and right and left lower-extremities (random), respectively. The average of the scores obtained will be recorded and used for analysis. | A week | |
Secondary | Anaerobic Power | Anaerobic power test will be evaluated with the electromagnetic ergometer (Ergomedic894E, Germany). The measurement method is to adjust and set the saddle height so that the knee of each participant could have a flexion of about 5°, and thus, 0.075 kp per unit weight will be supposed to be applied when reaching one's maximum speed. Afterward, a tester in synchronization with the computer verbally count a 5-second count down following warm-up and then verbally will give a "Start" signal, after which peak anaerobic power, average power, and fatigue index will be measured while encouraging participants to perform the exercise as much as possible for 30 seconds. | A week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |